Head-to-head · computed 2026-08-11
HealthRX vs Hims & Hers
HealthRX: HealthRX offers flat per-dose compounded GLP-1 pricing on 12-month and 3-month commitment plans. Its $99/mo semaglutide and $179/mo tirzepatide on the twelve-month plan rank among the lowest annualized figures in the market. No month-to-month rate is published. Hims & Hers: After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
Tirzepatide
| HealthRX | Hims & Hers | |
|---|---|---|
| All-in maintenance | $209/mo | $548/mo |
| Best plan rate | $179/mo | $548/mo |
| 12-month total | $2,148 | $6,576 |
| Status | Reported · 2026-07-18 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, HealthRX's $209 a month undercuts Hims & Hers's $548 by $339 a month at the 10 mg/wk maintenance basis — $4,068 across a year. HealthRX's figure is reported (captured 2026-07-18) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
HealthRX's tirzepatide ladder runs $209 a month on a three-month plan, and $179 a month on a twelve-month plan. Hims & Hers's runs $548 a month billed monthly. On the twelve-month basis HealthRX's $2,148 beats Hims & Hers's $6,576 by $4,428 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| HealthRX | Hims & Hers | |
|---|---|---|
| All-in maintenance | $133/mo | $453/mo |
| Best plan rate | $99/mo | $453/mo |
| 12-month total | $1,188 | $5,436 |
| Status | Reported · 2026-07-18 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, HealthRX's $133 a month undercuts Hims & Hers's $453 by $320 a month at the 2.4 mg/wk maintenance basis — $3,840 across a year. HealthRX's figure is reported (captured 2026-07-18) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
HealthRX's semaglutide ladder runs $133 a month on a three-month plan, and $99 a month on a twelve-month plan. Hims & Hers's runs $453 a month billed monthly. On the twelve-month basis HealthRX's $1,188 beats Hims & Hers's $5,436 by $4,248 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
HealthRX carries no membership fee against Hims & Hers's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, HealthRX is dose-flat — the price survives titration — while Hims & Hers's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
HealthRX
- MembershipNone
- Dose policyFlat — same price at every dose
- Commitment12-month or 3-month plans only; no month-to-month rate published
- CancellationPer provider terms; confirm at enrollment
- Pharmacyhealthrx.com (pharmacy partner not publicly named)
Hims & Hers
- Membership$149/mo
- Dose policyBrand list pricing by product
- CommitmentMembership month-to-month ($39 first month)
- CancellationCancel anytime
- PharmacyBrand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy
What our desk is watching on each
HealthRX: HealthRX publishes no month-to-month rate; the $99/mo sema and $179/mo tirz are 12-month plan rates. The lowest commitment available is the 3-month plan ($133 sema, $209 tirz). Reported status — RangeYourself verified 2026-07-18 on healthrx.com; our independent checkout is pending.
Hims & Hers: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Questions people ask
Is HealthRX or Hims & Hers cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does HealthRX vs Hims & Hers miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do HealthRX and Hims & Hers cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,148 at HealthRX and $6,576 at Hims & Hers — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: HealthRX · Hims & Hers. Official sites: HealthRX ↗ · Hims & Hers ↗. Nothing here is medical advice.